Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Recombinant allergens for immunotherapy.

Rudolf Valenta1, Verena Niederberger

  • 1Christian Doppler Laboratory for Allergy Research, Division of Immunopathology, Department of Pathophysiology, Center of Physiology and Pathophysiology, Medical University of Vienna, Vienna, Austria. rudolf.valenta@meduniwien.ac.at

The Journal of Allergy and Clinical Immunology
|March 6, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Involution of IgE sensitization to house dust mite allergen molecules by age.

Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology·2026
Same author

Irritant occupational exposure and specific-IgE sensitisation in the EGEA cohort.

Occupational and environmental medicine·2026
Same author

Discovery of tumor antigens in renal cell carcinoma and prospects for clinical application.

Frontiers in immunology·2026
Same author

Birch Pollen Exposure Boosts Mal d 1-Specific IgE and Sensitivity to Apple.

Allergy·2026
Same author

Reply.

The Journal of allergy and clinical immunology·2026
Same author

Algorithms in Allergy: General Allergen Molecule-Based Algorithm for Allergen-Specific Immunotherapy.

Allergy·2026
Same journal

Tamoxifen-driven neutrophil reprogramming protects from pulmonary Granulibacter bethesdensis infection in chronic granulomatous disease.

The Journal of allergy and clinical immunology·2026
Same journal

Clinical and transcriptomic characterization of mixed granulocytic COPD phenotype.

The Journal of allergy and clinical immunology·2026
Same journal

Dupilumab outcomes in pediatric asthma by early eosinophil status: post hoc analysis of VOYAGE/EXCURSION.

The Journal of allergy and clinical immunology·2026
Same journal

Maternal antibiotic exposure alters the newborn metabolomic profile and increases the risk of respiratory infections in offspring: a 13-year longitudinal birth cohort study.

The Journal of allergy and clinical immunology·2026
Same journal

Selective Elimination of Mast Cells via Siglec-6-Targeted Nanodelivery of Drug Payload.

The Journal of allergy and clinical immunology·2026
Same journal

Loss of epidermal miR-149 sensitizes to skin inflammation.

The Journal of allergy and clinical immunology·2026
See all related articles

Recombinant allergens offer consistent quality for allergy diagnostics and therapeutics. Clinical trials show recombinant allergen immunotherapy is effective and may lead to new treatment strategies.

Area of Science:

  • Biotechnology
  • Immunology
  • Allergy Research

Background:

  • Recombinant allergens provide defined molecules with consistent quality and quantity.
  • Allergen modification can reduce IgE-mediated side effects and enhance immunologic properties.
  • Recombinant allergens are valuable for both diagnostic and therapeutic applications in allergy.

Purpose of the Study:

  • To evaluate the efficacy and vaccination characteristics of recombinant allergen-based immunotherapy.
  • To explore the potential of modified recombinant allergens for improved immunotherapy.
  • To assess the promise of recombinant allergens for new treatment strategies and prophylactic vaccination.

Main Methods:

  • Production of recombinant allergens using DNA templates.

Related Experiment Videos

  • Modification of recombinant allergens to reduce allergenicity and improve immunologic properties.
  • Conducting injection immunotherapy trials with recombinant vaccines for pollen allergies.

    • Main Results:

    • Recombinant allergen-based immunotherapy demonstrated effective vaccination characteristics in clinical trials.
    • Recombinant allergen immunotherapy proved clinically effective in treating birch and grass pollen allergies.
    • The study confirmed the feasibility and efficacy of using recombinant allergens in immunotherapy.

    Conclusions:

    • Recombinant allergen immunotherapy is a clinically effective treatment option.
    • Recombinant allergens hold significant promise for advancing current immunotherapy practices.
    • Future applications may include novel treatment strategies and prophylactic allergy vaccination.